Vital Signs: Zika-Associated Birth Defects and Neurodevelopmental Abnormalities Possibly Associated with Congenital Zika Virus Infection - U.S. Territories and Freely Associated States, 2018.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rice Marion E, Galang Romeo R, Roth Nicole M, Ellington Sascha R, Moore Cynthia A, Valencia-Prado Miguel, Ellis Esther M, Tufa Aifili John, Taulung Livinson A, Alfred Julia M, Pérez-Padilla Janice, Delgado-López Camille A, Zaki Sherif R, Reagan-Steiner Sarah, Bhatnagar Julu, Nahabedian John F, Reynolds Megan R, Yeargin-Allsopp Marshalyn, Viens Laura J, Olson Samantha M, Jones Abbey M, Baez-Santiago Madelyn A, Oppong-Twene Philip, VanMaldeghem Kelley, Simon Elizabeth L, Moore Jazmyn T, Polen Kara D, Hillman Braeanna, Ropeti Ruta, Nieves-Ferrer Leishla, Marcano-Huertas Mariam, Masao Carolee A, Anzures Edlen J, Hansen Ransen L, Pérez-Gonzalez Stephany I, Espinet-Crespo Carla P, Luciano-Román Mildred, Shapiro-Mendoza Carrie K, Gilboa Suzanne M, Honein Margaret A
Аннотация
METHODS: Pregnancies with laboratory evidence of confirmed or possible Zika virus infection and infants resulting from these pregnancies are included in the U.S. Zika Pregnancy and Infant Registry (USZPIR) and followed through active surveillance methods. This report includes data on children aged ≥1 year born in U.S. territories and freely associated states. Receipt of reported follow-up care was assessed, and data were reviewed to identify Zika-associated birth defects and neurodevelopmental abnormalities possibly associated with congenital Zika virus infection.
RESULTS: Among 1,450 children of mothers with laboratory evidence of confirmed or possible Zika virus infection during pregnancy and with reported follow-up care, 76% had developmental screening or evaluation, 60% had postnatal neuroimaging, 48% had automated auditory brainstem response-based hearing screen or evaluation, and 36% had an ophthalmologic evaluation. Among evaluated children, 6% had at least one Zika-associated birth defect identified, 9% had at least one neurodevelopmental abnormality possibly associated with congenital Zika virus infection identified, and 1% had both.
CONCLUSION: One in seven evaluated children had a Zika-associated birth defect, a neurodevelopmental abnormality possibly associated with congenital Zika virus infection, or both reported to the USZPIR. Given that most children did not have evidence of all recommended evaluations, additional anomalies might not have been identified. Careful monitoring and evaluation of children born to mothers with evidence of Zika virus infection during pregnancy is essential for ensuring early detection of possible disabilities and early referral to intervention services.